Na Liu

ORCID: 0000-0001-5986-7467
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Alzheimer's disease research and treatments
  • Cholinesterase and Neurodegenerative Diseases
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Supramolecular Self-Assembly in Materials
  • Cytokine Signaling Pathways and Interactions
  • Asthma and respiratory diseases
  • Cell death mechanisms and regulation
  • Biofield Effects and Biophysics
  • Advanced Glycation End Products research
  • Genetics, Aging, and Longevity in Model Organisms
  • Protein Structure and Dynamics
  • Medicinal Plant Pharmacodynamics Research
  • Retinoids in leukemia and cellular processes
  • Natural Antidiabetic Agents Studies
  • Computational Drug Discovery Methods
  • Neuroscience and Neuropharmacology Research
  • S100 Proteins and Annexins
  • Medicinal Plants and Neuroprotection

Shandong University
2024

Shandong Provincial QianFoShan Hospital
2024

Xingtai Medical College
2021

Xingtai University
2021

Soochow University
2021

Xi'an Honghui Hospital
2020

Xi'an Jiaotong University
2020

Peking University
2019

Chengde Medical University
2016

Southeast University
2016

Alzheimer's disease (AD) is a prevalent neurodegenerative disorder characterized by β amyloid (Aβ) deposition and neurofibril tangles. It has been reported that bioflavonoid, quercetin, could ameliorate AD phenotypes in C. elegans mice. However, the mechanism underlying ameliorative effect of quercetin not fully understood yet. Drosophila models recapitulate AD-like phenotypes, such as shortened lifespan, impaired locomotive ability well defects learning memory. So this study, we...

10.18632/oncotarget.11963 article EN Oncotarget 2016-09-10

Alzheimer's disease (AD) is one of the neurodegenerative brain disorders inducing nearly half dementia cases, and diagnosis treatment AD are primary issues clinically. However, there a lack effective biomarkers drugs for therapeutics so far. In this study, bioinformatics analysis combined with an experimental verification strategy was used to identify quercetin targets treatment. First, differentially expressed genes in were identified by microarray data analysis. Second, quercetin,...

10.3389/fnagi.2020.589588 article EN cc-by Frontiers in Aging Neuroscience 2020-10-23

TTP488, an antagonist of the receptor for advanced glycation end-products, was evaluated as a potential treatment patients with mild-to-moderate Alzheimer's disease (AD). However, mechanism underlying protective action TTP488 against AD has not yet been fully explored.Healthy male rats were exposed to aberrant amyloid β (Aβ) 1-42. Lipopolysaccharide (LPS) and NOD-like family pyrin domain containing 1 (NLRP1) overexpression lentivirus injected activate NLRP1 inflammasome exacerbate AD....

10.6061/clinics/2021/e2348 article EN cc-by Clinics 2021-01-01

Background and purpose: The Bushenyiqi decoction (BYD), a contemporary prescription of traditional Chinese medicine (TCM), has been observed to significantly ameliorate asthma symptoms in patients based on clinical observations. Although multi-component multi-target characteristics are important attributes BYD treatment, its pharmacological effect the underlying mechanism action remain unclear. Method: Network pharmacology: asthma-related genes were retrieved from GeneCards OMIM database....

10.3389/fphar.2024.1361379 article EN cc-by Frontiers in Pharmacology 2024-03-25

Amyloid fibril surfaces can convert soluble proteins into toxic oligomers and are attractive targets for intervention of protein aggregation diseases. Thus far, molecules identified with inhibitory activity either large or flat cyclic compounds lacking in specificity. The main design difficulty is flatness amyloid the lack knowledge on binding interfaces. Here, we demonstrate, first time, a rational alpha-helical peptide inhibitors targeting amyloid-beta 40 (Aβ40) surfaces, based our silico...

10.1016/j.isci.2019.06.022 article EN cc-by-nc-nd iScience 2019-06-18

Excitotoxicity refers to the ability of excessive extracellular excitatory amino acids damage neurons via receptor activation. It is a crucial pathogenetic process in neurodegenerative diseases. TP53 confirmed be involved excitotoxicity. demonstrated that induced glycolysis and apoptotic regulator (TIGAR)-regulated metabolic pathway can protect against neuronal injury. However, role TIGAR excitotoxicity specific mechanisms still unknown. In this study, an vivo model was constructed...

10.1016/j.neuint.2021.105244 article EN cc-by-nc-nd Neurochemistry International 2021-11-24

5XFAD transgenic (Tg) mice express 5 human familial Alzheimer’s Disease (AD) gene mutations ‐ Amyloid Precursor Protein from the Swedish, Florida and London families, along with 2 in presenilin‐1. Their early onset brain pathology, accelerated Aβ 42 amyloid deposition, age‐dependent neurodegeneration cognitive decline, make these an attractive translatable AD model. We used behavioral, biochemical electrophysiological analyses to track changes mice, compared their age‐matched wild‐type mice....

10.1096/fasebj.28.1_supplement.lb556 article EN The FASEB Journal 2014-04-01

Welcome to the WIT Press eLibrary - home of Transactions Wessex Institute collection, providing on-line access papers presented at Institute's prestigious international conferences and from its State-of-the-Art in Science & Engineering publications.

10.2495/hhme20131392 article EN WIT transactions on biomedicine and health 2014-04-01
Coming Soon ...